Andrew Hitron
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Natural product bioactivities and synthesis 2
- Cell death mechanisms and regulation 2
-
- Flavonoids in Medical Research 2
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Young‐Ok Son (6 shared papers)Zhuo Zhang (5 shared papers)Poyil Pratheeshkumar (6 shared papers)Amit Budhraja (7 shared papers)Songze Ding (6 shared papers)Xianglin Shi (5 shared papers)Jia Luo (4 shared papers)Jeong‐Chae Lee (3 shared papers)
- Journals
- PLoS ONE (2 papers)Toxicology and Applied Pharmacology (2 papers)Molecular Cancer Therapeutics (1 paper)International Journal of Oncology (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Andrew Hitron
8 papers receiving 730 citations
Peers
Comparison fields: 5 of 92
- Biochemistry 140
- Applied Microbiology and Biotechnology 27
- Molecular Medicine 43
- Toxicology 29
- Cancer Research 124
Countries citing papers authored by Andrew Hitron
This map shows the geographic impact of Andrew Hitron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hitron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hitron more than expected).
Fields of papers citing papers by Andrew Hitron
This network shows the impact of papers produced by Andrew Hitron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hitron. The network helps show where Andrew Hitron may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Hitron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 235 | |
| 2 | 2012 | 143 | |
| 3 | 2013 | 138 | |
| 4 | 2012 | 103 | |
| 5 | 2011 | 82 | |
| 6 | 2013 | 42 | |
| 7 | 2013 | 6 | |
| 8 | 2011 | 2 |
About Andrew Hitron
Andrew Hitron is a scholar working on Molecular Biology, Pharmacology, Health, Toxicology and Mutagenesis, Biochemistry and Cancer Research, having authored 8 papers that have together received 751 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (2 papers), Natural product bioactivities and synthesis (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cell death mechanisms and regulation (2 papers), Flavonoids in Medical Research (2 papers), Phytochemicals and Antioxidant Activities (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Chromium effects and bioremediation (1 paper). The work is most often cited by research in Biochemistry (140 citations), Applied Microbiology and Biotechnology (27 citations), Molecular Medicine (43 citations), Toxicology (29 citations) and Cancer Research (124 citations). Andrew Hitron has collaborated with scholars based in United States, China and India. Frequent co-authors include Young‐Ok Son, Zhuo Zhang, Poyil Pratheeshkumar, Amit Budhraja, Songze Ding, Xianglin Shi, Jia Luo, Jeong‐Chae Lee, Gang Chen and Xin Wang. Their work appears in journals such as PLoS ONE, Toxicology and Applied Pharmacology, Molecular Cancer Therapeutics, International Journal of Oncology and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.